Bexarotene Capsule, Liquid Filled
Product Images NDC 43975-315

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bexarotene (NDC 43975-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

FDA Label Image

Image 02

Image 02
Label for Bexarotene Capsules, 75 mg, liquid-filled oral capsules, manufactured by ANI Pharmaceuticals, Inc. The label states each capsule contains 75 mg of bexarotene and lists inactive ingredients. Storage instructions, patient information warnings, and barcode with NDC 43975-315-10 are visible. Package contains 100 capsules, Rx only.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of bexarotene, showing its molecular framework with aromatic rings, methyl groups, and a carboxylic acid functional group as part of the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.